The treatment of juxta-epiphysial
We randomised 50 patients with extracapsular
We report our experience with carbon-fibre reinforced plastic (CFRP) plates in the management of 19 problem
A prospective study of factors which might help to predict mortality in patients with intracapsular
We reviewed ten patients with metastatic carcinoma and impending pathological
We report three patients having transoral fusion at C2/3 or C3/4 after
Aims. This study aims to assess first, whether mutations in the epidermal
growth factor receptor (EGFR) and Kirsten rat sarcoma (kRAS) genes
are associated with overall survival (OS) in patients who present
with symptomatic bone metastases from non-small cell lung cancer
(NSCLC) and secondly, whether mutation status should be incorporated into
prognostic models that are used when deciding on the appropriate
palliative treatment for symptomatic bone metastases. Patients and Methods. We studied 139 patients with NSCLC treated between 2007 and 2014
for symptomatic bone metastases and whose mutation status was known.
The association between mutation status and overall survival was
analysed and the results applied to a recently published prognostic
model to determine whether including the mutation status would improve
its discriminatory power. Results. The median OS was 3.9 months (95% confidence interval (CI) 2.1
to 5.7). Patients with EGFR (15%) or kRAS mutations (34%) had a
median OS of 17.3 months (95% CI 12.7 to 22.0) and 1.8 months (95%
CI 1.0 to 2.7), respectively. Compared with EGFR-positive patients,
EGFR-negative patients had a 2.5 times higher risk of death (95%
CI 1.5 to 4.2). Incorporating EGFR mutation status in the prognostic
model improved its discriminatory power. Conclusion. Survival prediction models for patients with symptomatic bone
metastases are used to determine the most appropriate (surgical)
treatment for painful or
We evaluated the biomechanical properties of two different methods of fixation for unstable
The classification of intra-articular
There is currently limited information available
on the benefits and risks of extended thromboprophylaxis after hip fracture
surgery. SAVE-HIP3 was a randomised, double-blind study conducted
to evaluate the efficacy and safety of extended thromboprophylaxis
with the ultra-low molecular-weight heparin semuloparin compared
with placebo in patients undergoing hip
One hundred patients who had sustained a
1. The posterior Monteggia
A
1. Seventy-four patients over the age of seventy with either subcapital or intertrochanteric fracture have been investigated for evidence of osteomalacia. To establish an index of suspicion the incidence of biochemically defined osteomalacia has been compared with quantitative histology in this group. 2. Whereas no significant difference in the incidence of the disease was noted in the comparison of subcapital with trochanteric
We compared two conservative methods of treating Weber B1 (Lauge-Hansen supination-eversion 2) isolated
1. Three cases of severe retroperitoneal haemorrhage complicating
Of 92 children reviewed three to five years after treatment for
We describe three cases of traumatic myositis ossificans in which
We report the results of a randomised trial to determine the effects of skin traction on 252 patients awaiting surgery for
We describe a method of internal fixation for femoral neck